<DOC>
	<DOCNO>NCT01193452</DOCNO>
	<brief_summary>This phase II trial assumption S-1 combine Leucovorin may better efficacy safety simplify 5-FU/LV infusion therapy elderly patient advance colorectal cancer .</brief_summary>
	<brief_title>S-1/Leucovorin ( SL ) Versus sLV5FU2 First-line Treatment Elderly Patients With Colorectal Cancer</brief_title>
	<detailed_description>This randomized phase Ⅱ study , S-1 use combination leucovorin elderly patient advance colorectal cancer first-line treatment , compare sLV5FU2 therapy . The aim study determine efficacy safety S-1/LV elderly patient first-line setting . The secondary endpoint progression free survival , overall survival , quality life also evaluate .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Signed write informed consent Oral medication acceptable Histologically confirm colorectal carcinoma Male female ≥ 65 year age No prior chemotherapy , radiotherapy , target therapy immunotherapy , except adjuvant chemotherapy interval ≥ 180 day ) Presence least one target lesion measurable CT scan MRI , within 15 day prior trial The lab value within 2 week prior trial meet : PLT ≥7.5*10^4/mm3 ANC≥2000/mm3 HB≥100g/L Total bilirubin &lt; upper limit normal level ALT/AST/ALP &lt; 2.5 x UNL ( &lt; 5 x UNL patient liver bone metastasis ) Serum creatinine &lt; UNL Performance status ( ECOG ) 0~1 Life expectation longer 90 day Allergy S1 , fluorouracil leucovorin Any investigational agent ( ) within 4 week prior entry Previous currently exposure certain drug prove influence blood drug concentration Active infection Severe organ failure disease , include : intestinal obstruction , pulmonary fibrosis , uncontrolled diabetes mellitus , clinically relevant coronary disease , cardiovascular disorder myocardial infarction , renal liver failure , severe psychiatric illness , cerebral vascular disease sever GI ulcer need blood infusion . Uncontrolled hydrothorax , ascites hydropericardium Multiple bone metastatic lesion Brain metastasis Chronic diarrhea digestive disfunction Previous malignancy ( except colorectal cancer , history basal cell carcinoma skin preinvasive carcinoma cervix adequate treatment ) Strong willingness receive surgery highly potential intestinal obstruction may need surgery intervention Other condition primary investigate investigator consider unsuitable trial</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>elderly patient</keyword>
	<keyword>advanced colorectal cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>S-1</keyword>
	<keyword>5-fluorouracil</keyword>
	<keyword>leucovorin</keyword>
</DOC>